{
  "cik": 1818382,
  "cik_padded": "0001818382",
  "entityName": "Humacyte, Inc.",
  "fiscal_years": [
    {
      "accn": "0001818382-26-000004",
      "filed": "2026-03-27",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 884000.0,
        "cash": 50497000.0,
        "eps_diluted": -0.26,
        "free_cash_flow": -105926000.0,
        "net_income": -40833000.0,
        "operating_cash_flow": -105042000.0,
        "operating_income": -108137000.0,
        "revenue": 2038000.0,
        "stockholders_equity": 3109000.0,
        "total_assets": 116366000.0,
        "total_liabilities": 113257000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 36.42875522676102,
        "roa_avg2y": -0.32121870058763835,
        "roa_period_end": -0.35090146606397066,
        "roe_avg2y": 1.6478208232445521
      }
    },
    {
      "accn": "0001818382-26-000004",
      "filed": "2026-03-27",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1572000.0,
        "cash": 44937000.0,
        "eps_diluted": -1.26,
        "free_cash_flow": -99694000.0,
        "net_income": -148701000.0,
        "operating_cash_flow": -98122000.0,
        "operating_income": -114398000.0,
        "stockholders_equity": -52669000.0,
        "total_assets": 137872000.0,
        "total_liabilities": 190541000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -1.1176534696255096,
        "roa_period_end": -1.0785438667749796,
        "roe_avg2y": 7.601717659688674
      }
    },
    {
      "accn": "0001818382-26-000004",
      "filed": "2026-03-27",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2280000.0,
        "cash": 80448000.0,
        "eps_diluted": -1.07,
        "free_cash_flow": -75585000.0,
        "net_income": -110776000.0,
        "operating_cash_flow": -73305000.0,
        "operating_income": -100047000.0,
        "stockholders_equity": 13546000.0,
        "total_assets": 128223000.0,
        "total_liabilities": 114677000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 8.465746345784734,
        "roa_avg2y": -0.6662717088940681,
        "roa_period_end": -0.8639323678279248,
        "roe_avg2y": -1.6980547848613516
      }
    },
    {
      "accn": "0001818382-25-000034",
      "filed": "2025-03-31",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1048000.0,
        "cash": 149772000.0,
        "eps_diluted": -0.12,
        "free_cash_flow": -72177000.0,
        "net_income": -11965000.0,
        "operating_cash_flow": -71129000.0,
        "operating_income": -84578000.0,
        "stockholders_equity": 116928000.0,
        "total_assets": 204302000.0,
        "total_liabilities": 87374000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 0.7472461685823755,
        "roa_avg2y": -0.04875365448674198,
        "roa_period_end": -0.05856526123092285,
        "roe_avg2y": -0.1000828098468436
      }
    },
    {
      "accn": "0001818382-24-000040",
      "filed": "2024-03-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 220000.0,
        "cash": 217502000.0,
        "eps_diluted": -0.66,
        "free_cash_flow": -81410000.0,
        "net_income": -26477000.0,
        "operating_cash_flow": -81190000.0,
        "operating_income": -81208000.0,
        "stockholders_equity": 122174000.0,
        "total_assets": 286533000.0,
        "total_liabilities": 164359000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 1.3452862311130027,
        "roa_avg2y": -0.13466727361966935,
        "roa_period_end": -0.09240471429119858,
        "roe_avg2y": 0.23210880894877337
      }
    },
    {
      "accn": "0001818382-23-000016",
      "filed": "2023-03-24",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 318000.0,
        "cash": 39929000.0,
        "eps_diluted": -11.54,
        "free_cash_flow": -55886000.0,
        "net_income": -66524000.0,
        "operating_cash_flow": -55568000.0,
        "operating_income": -64600000.0,
        "stockholders_equity": -350317000.0,
        "total_assets": 106688000.0,
        "total_liabilities": 36016000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.6235377924415118,
        "roe_avg2y": 0.2081786247956126
      }
    },
    {
      "accn": "0001818382-22-000011",
      "filed": "2022-03-29",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -288788000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001818382-26-000004",
    "filed": "2026-03-27",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001818382.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001818382.json"
  },
  "ticker": "HUMA"
}